Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=70ba391c-a422-41a0-88d2-a973679439e4 Date 11/15/2013 Company Name DapperJobs Mailing Address Undisclosed Cambridge, MA 02142 Company Description We’re taking lessons learned from online dating and applying it to the job search process. Current culture fit solutions and tools are downstream from the interview process – beginning at the interview process and beyond – DapperJobs is … Continue reading “DapperJobs Secures $20,000 Seed Round”
Category: Boston
Achievery Lands $20,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f74c5ee7-fab1-4dc2-a76e-e456e232c3cd Date 11/15/2013 Company Name Achievery Mailing Address PO Box 23084 Providence, RI 02903 Company Description Achievery is a global platform for recognizing and verifying new and emerging skills, standards, and credentials. Using Achievery, organizations can make, manage, and issue, verifiable digital credentials and badges. Website http://www.achievery.com Transaction Type Accelerator Transaction Amount … Continue reading “Achievery Lands $20,000 Seed Funding”
Accessibility Now Secures $20,000 Seed Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4deb4900-6cff-403f-a9d7-e6b67adecb7d Date 11/15/2013 Company Name Accessibility Now Mailing Address 1 West Exchange St Providence, RI 02903 Company Description The Accessibility Now online service is a powerful accessibility testing suite that is simple to use. The system scans websites for their compliance to Section 508 standards, WCAG 2.0 standards, and also checks for … Continue reading “Accessibility Now Secures $20,000 Seed Round”
In Defense of Sarepta’s Chris Garabedian
Anyone who follows the biotechnology industry surely is aware of the setback Cambridge, MA-based Sarepta Therapeutics (NASDAQ: [[ticker:SRPT]]) experienced this week after FDA changed their mind about the company’s ability to request early approval for its Duchenne Muscular Dystrophy drug, eteplirsen, on the basis of an encouraging Phase IIb study of 12 patients. However, the … Continue reading “In Defense of Sarepta’s Chris Garabedian”
Saxena, Hirschtick, Wolfram to Talk Big Data and Devices on 11/21
What can we learn about big data from the founders of Netezza, SolidWorks, and Wolfram Research? Quite a bit, I wager. And we will, one week from today, at our “D2: The Future of Data and Devices” conference. It’s all going down on Thursday, Nov. 21, at the Fidelity Center for Applied Technology in Boston, … Continue reading “Saxena, Hirschtick, Wolfram to Talk Big Data and Devices on 11/21”
Ovuline Takes Geeky Approach to Pregnancy Tracking with Ovia App
For a lot of people who get pregnant, the freak-out-and-gather-information phase still looks a lot like it did decades ago: stockpiling thousands of pages of advice books, and trying to burn through them all without gagging on all the conflicting pointers. It’s not a terribly efficient way to gather information. But anyone who’s tried to … Continue reading “Ovuline Takes Geeky Approach to Pregnancy Tracking with Ovia App”
The Future of Microsoft Research: One on One With New Boss Peter Lee
How do you help invigorate the Microsoft machine? Well, for Peter Lee, the answer lies in the frontiers of computer science. Lee is the new managing director of Microsoft Research, the company’s global research arm. His job is to help his parent company, not always quick on the uptake with emerging technology, understand the latest … Continue reading “The Future of Microsoft Research: One on One With New Boss Peter Lee”
New Enterprise Associates Sets up Shop in Kendall Square
New Enterprise Associates has had a hand in a number of Boston’s biotech startups over the years. But it wasn’t until now that the big VC firm officially put a physical footprint in the biotech cluster in Cambridge, MA. NEA today is announcing that it has opened an office in Kendall Square. It’s on the … Continue reading “New Enterprise Associates Sets up Shop in Kendall Square”
Catabasis Pharmaceuticals Receives $32,400,000 Series B Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94d95569-f2a9-45e7-b981-907666ce6f10 Date 11/14/2013 Company Name Catabasis Pharmaceuticals Mailing Address One Kendall Square Bldg. 1400E Cambridge, MA 02139 Company Description At Catabasis we are dedicated to the discovery and development of innovative, effective and safe medicines to treat inflammatory and metabolic diseases. We have assembled a team of highly motivated and experienced scientists … Continue reading “Catabasis Pharmaceuticals Receives $32,400,000 Series B Financing”
A Year After TechStars, Fetchnotes Focuses on Stickier Sharing
When we last caught up with the University of Michigan student startup Fetchnotes, the team was preparing for a stint in the elite TechStars Boston accelerator, the first U-M student startup to do so. Now, a year later, the digital note-capturing/life organizing service is relaunching today with a majorly overhauled iPhone app that includes a … Continue reading “A Year After TechStars, Fetchnotes Focuses on Stickier Sharing”
FlightCar Opens in LA—Hear CEO at Xconomy’s Hardtech Event 12/9
[Updated 12:10 pm] Rujul Zaparde and his friends weren’t purposely looking to unlock a legendarily tough business challenge when they founded FlightCar, a venture-backed startup that offers cheap parking for travelers who rent their wheels to someone else. “We really thought this was a cool idea, and we really wanted to test this out,” Zaparde … Continue reading “FlightCar Opens in LA—Hear CEO at Xconomy’s Hardtech Event 12/9”
Brian Shin Raises $4.5M for Mustbin, Looks to Mobilize Your Personal Data
Brian Shin has a good friend who lost everything in Hurricane Sandy. Unfortunately for him, Mustbin did not exist yet. If it did, Shin says, his friend could have at least made digital copies of his most precious papers such as passports, insurance forms, taxes, contracts, and photos. “His life would be so much better,” … Continue reading “Brian Shin Raises $4.5M for Mustbin, Looks to Mobilize Your Personal Data”
Shuttersong Lands $875,000 Seed Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2c613ee2-fe3c-45a3-a99a-37bf2cb68ce6 Date 11/13/2013 Company Name Shuttersong Mailing Address 41 Sawyer Road Wellesley Hills, MA 02481 Company Description While cleaning out his office last summer, Shuttersong’s founder William Agush discovered a photo of his son taken in 1995 in a frame with a button marked play. Upon pressing it, there was the voice … Continue reading “Shuttersong Lands $875,000 Seed Funding”
AppNeta Garners $7,999,998 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=42ac735a-e91a-4a5d-9ad6-47a13aea9728 Date 11/13/2013 Company Name AppNeta Mailing Address 285 Summer Street 4th Floor Boston, MA 02210 Company Description AppNeta provides the only Application Performance Management (APM) solution to offer broad application performance monitoring integrated with deep network performance and end user experience insight. Website http://www.appneta.com Transaction Type Venture Equity Transaction Amount $7,999,998 … Continue reading “AppNeta Garners $7,999,998 New Funding”
CareBooker Garners $200,000 Seed Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=296125dc-e1ef-4cd2-9683-f348a48e2c10 Date 11/13/2013 Company Name CareBooker Mailing Address Undisclosed Norwalk, CT 06854 Company Description CareBooker is the best place to find and book care for the whole family all under one roof, from child care, pet care, tutoring & lessons, to house cleaning, sports & fitness, and senior care. Website http://www.carebooker.com Transaction … Continue reading “CareBooker Garners $200,000 Seed Financing”
Boston Roundup: Formlabs, Yesware, Globoforce, Shuttersong
Catching up after the long weekend, here’s a bit of Boston-area tech business spanning lawsuits, acquisitions, IPOs, and small fundraising rounds: —It looks like Somerville, MA-based Formlabs, a 3D printing startup that recently raised $19 million, hasn’t quite shed a lingering patent lawsuit. South Carolina-based 3D Systems filed to dismiss its patent lawsuit against Formlabs … Continue reading “Boston Roundup: Formlabs, Yesware, Globoforce, Shuttersong”
Xconomy Xchange: Healthcare Gets Personal
Personal health and wellness is the latest technology craze. From wearable activity monitors to consumer health management to the “quantified self” movement, startups, big companies, and investors are all getting into the game. But there’s something deeper going on: A convergence of access to our personal information on genomics and physiology with smarter software and … Continue reading “Xconomy Xchange: Healthcare Gets Personal”
Healthcare Gets Personal: George Church to Keynote Our Dec. 12 Event
Say what you want about Obamacare, aka the Affordable Care Act. Innovation is coming fast to healthcare—and it’s increasingly bringing the power of technology right down to the individual. Whether it’s super-crunching your genome, the latest fitness apps or wearables, or new therapeutic games (yes, games that make you healthier), an array of advances are … Continue reading “Healthcare Gets Personal: George Church to Keynote Our Dec. 12 Event”
Sarepta Shares Crumble As FDA Calls New Drug Application “Premature”
The question of whether Sarepta Therapeutics could file for FDA approval of its Duchenne Muscular Dystrophy drug based on a tiny, yet promising set of data from a mid-stage clinical trial has been one of the biggest biotech questions of the year. The FDA provided the answer today, and it wasn’t the one the Cambridge, … Continue reading “Sarepta Shares Crumble As FDA Calls New Drug Application “Premature””
Time to Come Clean: Why A High-Tech Guy Envies the Low-Tech World
I’m ready to confess that I’ve been basking in a particular drug-induced fantasy for a number of years. It’s a different type than we usual read about, and I suspect it’s shared by a fair number of other folks who work in biopharma. We dream of the day when a medicine we created begins to … Continue reading “Time to Come Clean: Why A High-Tech Guy Envies the Low-Tech World”
New Roomba Is Key to iRobot’s Home of the Future—and Its Business
The godfather of commercial robotics, Bedford, MA-based iRobot, has a brand new Roomba coming out today. What could possibly be exciting about a new robot vacuum cleaner? You probably know the Roomba has been around for many years (since 2002). You may also know that its parent, iRobot (NASDAQ: [[ticker:IRBT]]), has sold 10 million home … Continue reading “New Roomba Is Key to iRobot’s Home of the Future—and Its Business”
Zalicus Pain Drug Flops in Two Key Clinical Studies
Zalicus has been waiting for years to see if its reformulation work on a failed pain drug would lead to success in clinical trials. Unfortunately for the Cambridge, MA-based company, it’s just meant more of the same disappointing results. Zalicus said today that its experimental pain drug, Z160, missed its mark in two mid-stage clinical … Continue reading “Zalicus Pain Drug Flops in Two Key Clinical Studies”
How Alkermes Survived a Brush With Death
Most every biotech company with some mileage has had at least one near-death experience. Maybe the key experiment failed, or a dangerous side effect emerged late in the game. Maybe a rich competitor decided to squash the little guy with a frivolous intellectual property lawsuit. Maybe a key partner bailed for whatever reason. Maybe the … Continue reading “How Alkermes Survived a Brush With Death”
Zalicus Awaits Day of Reckoning, Braces For Key Pain Drug Results
Like any biotech about to release data from a key trial, Zalicus (NASDAQ: [[ticker:ZLCS]]) is at a crossroads. Imminently, Cambridge, MA-based Zalicus will publish the top-line numbers from two mid-stage clinical trials of an experimental pain drug called Z160. The stakes are big for Zalicus, because this is its best shot to show investors—or a … Continue reading “Zalicus Awaits Day of Reckoning, Braces For Key Pain Drug Results”
KleerMail Garners $1,324,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=36644ccb-a606-4bff-9a12-31c6f6247421 Date 11/11/2013 Company Name KleerMail Mailing Address 800 Boylston Street 16th Floor Boston, MA 02199 Company Description With KleerMail, every Direct Mail program generates optimal ROI irrespective of the expertise or involvement of our clients. KleerMail delivers the most efficient technology solution in the industry, allowing every marketer to include Direct … Continue reading “KleerMail Garners $1,324,000 New Funding Round”
HealthFleet Receives $2,983,723 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=51d2ead1-9a9e-40cc-b034-fe3aa9d4c14c Date 11/11/2013 Company Name HealthFleet Mailing Address 50 Washington Street 9th Floor Norwalk, CT 06854 Company Description With HealthFleet, proven health programs can be delivered in a scalable controllable way, outside of treatment facilities, allowing our partners to lower operating expenses, increase revenues and improve outcomes. Website http://www.healthfleet.com Transaction Type Debt … Continue reading “HealthFleet Receives $2,983,723 New Financing”
Apple’s Weakness: Customer Loyalty Has Its Limits
If you’re ever forced to read a public company’s annual report, turn first to the “risk factors” section, which is always the most entertaining. This is where companies are required to disclose all of the things that could go terribly wrong with their businesses. It’s a Wall Street version of Edward Gorey’s Gashlycrumb Tinies (“A … Continue reading “Apple’s Weakness: Customer Loyalty Has Its Limits”
East Coast Biotech Roundup: Arno, Accelerate LI, Immunogen, & More
Abstracts for next month’s annual meeting of the American Society of Hematology began pouring in Thursday, but plenty more happened along the East Coast before investors began combing through those market-moving clinical trial summaries. Those stories below: —Why are Opko Health (NYSE: [[ticker:OPK]]) and the founder of private equity firm TPG Capital circling Flemington, NJ-based … Continue reading “East Coast Biotech Roundup: Arno, Accelerate LI, Immunogen, & More”
LevelUp’s Latest Fundraise Intended to Get It to “Break-Even”
We’ve got an answer about the latest fundraising round for LevelUp, the Boston-based mobile payments startup with a history of twists and turns–and big venture backing. In late September, LevelUp quietly filed SEC paperwork for a $7.5 million equity investment round. That came on top of the startup’s existing $41 million venture pot, but was … Continue reading “LevelUp’s Latest Fundraise Intended to Get It to “Break-Even””
Axe Falls on Ariad’s Workforce After Cancer Drug Blowup
It wasn’t long ago that Ariad Pharmaceuticals (NASDAQ: [[ticker:ARIA]]) was building a massive new headquarters in Cambridge, MA, to help roll out its first FDA-approved cancer drug, ponatinib (Iclusig). Just a few months later, it’s on the defensive, cutting almost half of its workforce. Ariad announced plans today to cut 160 jobs, about 40 percent … Continue reading “Axe Falls on Ariad’s Workforce After Cancer Drug Blowup”
Agenda Live for D2: The Future of Data and Devices, Nov. 21 Forum
Wolfram, Pentland, Chang, Hirschtick, Lynch, Rae. Big Data, Connected Devices, the Cloud, Security, Analytics. They are all part of a fantastic lineup of people and topics on tap for D2: The Future of Data and Devices, Xconomy’s half-day forum that will take place in downtown Boston on the afternoon of November 21. And now the … Continue reading “Agenda Live for D2: The Future of Data and Devices, Nov. 21 Forum”
Boston Roundup: Facebook, Sold, Rethink Robotics, RallyPoint
Hey look, a story that has nothing to do with the Twitter IPO! How unusual. Instead, we’ve got a few news tidbits about tech companies big and small opening offices, getting acquired, and raising money: —Facebook, infamously started in the Boston area before decamping to California, is finally publicly acknowledging that it’s set up an … Continue reading “Boston Roundup: Facebook, Sold, Rethink Robotics, RallyPoint”
Surviving Exponential Growth: Lessons from Network Solutions
At the beginning of 1995, there were only about 71,000 domain names in the entire world, and a grand total of about 16 million Internet users. This was the year that Science Applications International Corporation (SAIC), then based in San Diego, acquired Network Solutions—a small technology company in the northern Virginia suburbs of Washington, DC. … Continue reading “Surviving Exponential Growth: Lessons from Network Solutions”
LevelUp, Mass. AG Coakley Take Aim at “Patent Trolls”
LevelUp, a Boston-based mobile payments startup bankrolled by Google Ventures, is joining with the attorney general of Massachusetts to scold the people behind frivolous patent lawsuits and join growing calls for changes to U.S. intellectual property laws. Seth Priebatsch, LevelUp’s CEO, noted that his young company has been sued over patents four times so far … Continue reading “LevelUp, Mass. AG Coakley Take Aim at “Patent Trolls””
Karyopharm Prices Upsized IPO at $16 Per Share, Begins Trading Today
Karyopharm Therapeutics got a warm welcome from investors last night. The Natick, MA-based biotech said late Tuesday that it priced its IPO at $16 per share, at the high end of its projected $14 to $16 per share range. Karyopharm sold 6.8 million shares at the IPO price, up from the 5.7 million it initially … Continue reading “Karyopharm Prices Upsized IPO at $16 Per Share, Begins Trading Today”
Curis Shares Tumble As Cancer Drug Slapped With FDA Clinical Hold
When Curis (NASDAQ: [[ticker:CRIS]]) licensed a cancer drug from Genentech last year, it was hoping for a repeat performance of the development deal that led to its first FDA approval. Given the troubling signs it’s just seen in an early-stage trial, however, that might be a tougher task this time around. Lexington, MA-based Curis said … Continue reading “Curis Shares Tumble As Cancer Drug Slapped With FDA Clinical Hold”
While Healthcare.gov Scrambles, Private Exchanges Are Off to the Races
All eyes are on the hullaballoo created by the challenges at Healthcare.gov and several of the states’ public insurance exchanges. Yet all the while, like in a magic show, attention has been diverted from the real action going on elsewhere. Quietly and in a relatively drama-free way, the private health insurance exchanges are busily taking … Continue reading “While Healthcare.gov Scrambles, Private Exchanges Are Off to the Races”
Tiggly Brings Edtech Apps and Shapes for Preschoolers to Apple Stores
The world of tablets may be flat, but Tiggly in New York is bringing new dimensions to iPads with physical shapes it says can teach motor skills to preschoolers and younger tikes. Starting Tuesday, Tiggly’s package of “appcessories” will be on shelves at Apple stores with the rollout planned to span locations in North America, … Continue reading “Tiggly Brings Edtech Apps and Shapes for Preschoolers to Apple Stores”
Immunogen Halts Study as Cancer Drug Flops, Shares Fall
Immunogen has been trying to prove that it can turn its “smart bomb” drug technology into a successful drug without the help of a big pharma partner. Those plans took a big hit today as its lead drug candidate flopped in a mid-stage clinical trial. Waltham, MA-based Immunogen (NASDAQ: [[ticker:IMGN]]) today stopped a Phase II … Continue reading “Immunogen Halts Study as Cancer Drug Flops, Shares Fall”
CyPhy Works Gets $7M More to Make Commercial Drone Program Fly
The race to get more drones into American skies is definitely on, and Boston-area entrepreneurs are jockeying to secure their spot. CyPhy Works, the drone startup headed by iRobot co-founder Helen Greiner, says it now has another $7 million to aid in that task. The new investment was led by Lux Capital, with General Catalyst, … Continue reading “CyPhy Works Gets $7M More to Make Commercial Drone Program Fly”
RapidMiner Lands $5,000,000 Series A Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=df1d2be1-0479-4cc7-a901-20fc5396533b Date 11/5/2013 Company Name RapidMiner Mailing Address 101 Main St 15th Floor Cambridge, MA 02139 Company Description RapidMiner provides software, solutions, and services in the fields of predictive analytics, data mining, and text mining. We automatically and intelligently analyze data – including databases and text – on a large scale. Website … Continue reading “RapidMiner Lands $5,000,000 Series A Financing”
Cyphy Works Garners $7,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9821a47e-6091-4f20-8ef1-7b50d24b3232 Date 11/5/2013 Company Name Cyphy Works Mailing Address 16C Electronics Ave. Danvers, MA 01923 Company Description The company is a robotics startup that is developing unmanned aerial vehicle technologies. Website http://www.cyphyworks.com Transaction Type Venture Equity Transaction Amount $7,000,000 Transaction Round Undisclosed Proceeds Purposes As part of this funding round, CyPhy Works … Continue reading “Cyphy Works Garners $7,000,000 New Funding Round”
Stephen Wolfram to Speak @ D2: Future of Data and Devices on Nov. 21
An amazing lineup just got even more amazing. Stephen Wolfram has been added to the marquee speaker list for D2: The Future of Data and Devices, Xconomy’s half-day forum set for the afternoon of November 21. Tickets have been going fast, but you definitely can still register here. The Saver rate ends on Thursday, so … Continue reading “Stephen Wolfram to Speak @ D2: Future of Data and Devices on Nov. 21″
RapidMiner Reels In $5M, Makes Big Push in Boston for Big Data
Just when the hype of big data is wearing off is when real businesses are getting built. Take a look at RapidMiner, a German analytics company that’s setting up U.S. headquarters in the Boston area as it looks to expand in North America. RapidMiner (formerly known as Rapid-I) has been around since 2006 but has … Continue reading “RapidMiner Reels In $5M, Makes Big Push in Boston for Big Data”
Which Regions Are Churning Out the Most Biotech IPOs?
If you’ve got ambitions to start and build a biotech company that may someday go public, where is the best place to make it happen? Which regional clusters provide the most fertile places where people, scientific ideas, technology, and money come together to build NASDAQ-worthy biotech companies? This is just one more way of looking … Continue reading “Which Regions Are Churning Out the Most Biotech IPOs?”
CallMiner Receives $2,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=687659fa-d712-405e-82a7-98ec351566df Date 11/4/2013 Company Name CallMiner Mailing Address 230 Third Ave Waltham, MA 02451 Company Description CallMiner is the leading provider of speech analytics solutions that deliver near real-time customer intelligence from Call Center recordings. CallMiner’s advanced suite of applications enables managers and executives to gain insight into why customers call, what … Continue reading “CallMiner Receives $2,000,000 New Financing Round”
Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’
Genentech is the “goose that keeps laying golden eggs” in the words of one biotech entrepreneur I spoke with last week, who worked there as a scientist in the ‘80s. Another golden egg just came out today. South San Francisco-based Genentech, a unit of Roche, said today it has won FDA approval of obinutuzumab (Gazyva), … Continue reading “Genentech Does it Again, Wins FDA Approval for ‘Son of Rituxan’”
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More
[Updated, 9:22 am ET] The city of Boston was in baseball euphoria this week as the Red Sox claimed their third championship in nine years—a sentence many New Englanders likely thought they’d never read in their lifetime (as much as it pains this Yankee fan to say, congrats to you Sawx fans out there). That … Continue reading “East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More”
6 Secrets to Slaying the E-Mail Monster
People have been complaining about the onslaught of e-mail almost since the day it was invented. We’ve all heard the statistics: Over 100 billion business e-mails are sent every day, with the average user sending and receiving about 100 messages per day. Reading and answering e-mail takes up 28 percent of the average worker’s day—about … Continue reading “6 Secrets to Slaying the E-Mail Monster”
Circle Garners $9,000,000 Series A Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=07e682b7-842e-4be2-91f3-983d87dd5d96 Date 11/1/2013 Company Name Circle Mailing Address 332 Congress Street 4th Floor Boston, MA 02210 Company Description Circle is about enabling global digital currency and transforming the world economy with secure, simple, and less costly technology for storing and using money. We’re as excited about Bitcoin and digital currency as we … Continue reading “Circle Garners $9,000,000 Series A Round”